SAINT in Postpartum Depression (PPD)
NCT: NCT07210255 · RECRUITING
Brief Summary
This study is a large, multi-site clinical trial testing whether Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT), a fast-acting form of repetitive transcranial magnetic stimulation (rTMS), can more effectively reduce symptoms of postpartum depression (PPD) compared to a sham treatment. It will enroll 192 women within 12 months postpartum who are experiencing depression that has not improved with standard care, and will track their progress for up to 12 months. The trial's main goal is to see if SAINT leads to reduction in depression severity in women with postpartum depression.
Frequently Asked Questions
What is SAINT in Postpartum Depression (PPD)?
SAINT in Postpartum Depression (PPD) is a clinical trial registered under NCT07210255. Current status: RECRUITING.
What is the status of NCT07210255?
The current status of NCT07210255 (SAINT in Postpartum Depression (PPD)) is: RECRUITING.
When did SAINT in Postpartum Depression (PPD) start?
SAINT in Postpartum Depression (PPD) started on 2025-11-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.